CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,633,552 | +4.5% | 561,600 | 0.0% | 0.21% | +8.7% |
| Q2 2023 | $3,476,304 | +160691.1% | 561,600 | 0.0% | 0.20% | +37.3% |
| Q1 2023 | $2,162 | +24.2% | 561,600 | 0.0% | 0.14% | +22.4% |
| Q4 2022 | $1,741 | -100.0% | 561,600 | -71.5% | 0.12% | -79.1% |
| Q3 2022 | $7,930,000 | -44.4% | 1,972,728 | -32.6% | 0.55% | -48.6% |
| Q2 2022 | $14,256,000 | -36.2% | 2,927,273 | +17.6% | 1.08% | -37.1% |
| Q1 2022 | $22,334,000 | -20.3% | 2,489,894 | 0.0% | 1.72% | +2.8% |
| Q4 2021 | $28,036,000 | -2.4% | 2,489,894 | +44.2% | 1.67% | +42.9% |
| Q3 2021 | $28,724,000 | -7.5% | 1,727,273 | +21.0% | 1.17% | +10.6% |
| Q2 2021 | $31,054,000 | – | 1,427,273 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |